Ezz Life Science Holdings Ltd has released a press release.
Response to ASX Aware Letter
Filed with ASX ·
6ix hasn’t read this filing yet.
EZZ Life Science Holdings Ltd. on 6ix
Earlier from EZZ Life Science
- FY24 Results Presentation
- FY24 Full Year Results Summary
- Preliminary Final Report
- EZZ Expands Portfolio with 4 Functional Food Products
- EZZ Targets US Expansion Receives Product Approvals from FDA
Later from EZZ Life Science
- Quarterly Activities/Appendix 4C Cash Flow Report
- EZZ Appoints United States Manufacturing Partner
- Interim Dividend Announcement
- EZZ Enters SE Asia with Multi Year Distribution Agreement
- Quarterly Activities / Appendix 4C Cashflow Report
Follow EZZ Life Science into a list and get an email when it puts out news.
Follow EZZ Life Science